ACID ALENDRONIC/COLECALCIFEROL ZENTIVA 70mg / 2800UI tablets medication leaflet

M05BB03 alendronic acid + cholecalciferol • Musculo-skeletal system | Drugs affecting bone structure and mineralization | Bisphosphonates, combinations

The combination of alendronic acid and colecalciferol (vitamin D3) is used for the prevention and treatment of osteoporosis, particularly in postmenopausal women or individuals at high risk of bone fractures. This combination helps maintain bone health by reducing bone loss and increasing bone density.

- Alendronic acid is a bisphosphonate that inhibits bone resorption by reducing the activity of osteoclasts (cells that break down bone). This helps prevent bone loss and strengthens bones.
- Colecalciferol (vitamin D3) enhances calcium absorption in the intestines and contributes to its effective utilization in the body, which is essential for bone health.

This combination is typically taken once a week, in the morning, on an empty stomach with a full glass of water. It is important to remain upright for at least 30 minutes after taking it to prevent esophageal irritation. Long-term use should be monitored by a doctor to avoid side effects such as gastrointestinal issues or hypercalcemia.

General data about ACID ALENDRONIC/COLECALCIFEROL ZENTIVA 70mg / 2800UI

Substance: alendronic acid + cholecalciferol

Date of last drug list: 01-06-2025

Commercial code: W63922002

Concentration: 70mg / 2800UI

Pharmaceutical form: tablets

Quantity: 4

Product type: generic

Price: 54.05 RON

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: PHARMATHEN INTERNATIONALS.A. - GRECIA

Holder: ZENTIVA, K.S. - REPUBLICA CEHA

Number: 10144/2017/02

Shelf life: 2 years

Concentrations available for alendronic acid + cholecalciferol

70mg/2800UI, 70mg/5600UI

Compensation lists for ACID ALENDRONIC/COLECALCIFEROL ZENTIVA 70mg / 2800UI ZENTIVA

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

54.05 RON

12.02 RON

42.03 RON

NHP 7 (C2) - Endocrine diseases

Price

Copayment

Patient

54.05 RON

50.56 RON

3.49 RON